Issue 2/2021
Content (26 Articles)
Immune microenvironment in different molecular subtypes of ductal breast carcinoma
Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Nima Rezaei
Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer
Shunchao Yan, Parama Dey, Yvonne Ziegler, Xin Jiao, Sung Hoon Kim, John A. Katzenellenbogen, Benita S. Katzenellenbogen
The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer
Yousif A. Kariri, Mansour Alsaleem, Chitra Joseph, Sami Alsaeed, Abrar Aljohani, Sho Shiino, Omar J. Mohammed, Michael S. Toss, Andrew R. Green, Emad A. Rakha
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments
Minami Hatono, Hirokuni Ikeda, Yoko Suzuki, Yukiko Kajiwara, Kengo Kawada, Takahiro Tsukioki, Mariko Kochi, Ken Suzawa, Takayuki Iwamoto, Hiromasa Yamamoto, Tadahiko Shien, Masaomi Yamane, Naruto Taira, Hiroyoshi Doihara, Shinichi Toyooka
Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-β/SMAD signaling
Rohit Kumar, Ekaterina Kuligina, Anna Sokolenko, Quadir Siddiqui, Nilesh Gardi, Sudeep Gupta, Ashok K. Varma, Syed K. Hasan
Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival
Dilara Koyuncu, Utsav Sharma, Erik T. Goka, Marc E. Lippman
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
Mei Zhou, Prabhakar Pitta Venkata, Suryavathi Viswanadhapalli, Bridgitte Palacios, Salvador Alejo, Yihong Chen, Yi He, Uday P. Pratap, Junhao Liu, Yi Zou, Zhao Lai, Takayoshi Suzuki, Andrew J. Brenner, Rajeshwar R. Tekmal, Ratna K. Vadlamudi, Gangadhara R. Sareddy
Patient-reported outcomes among women with unilateral breast cancer undergoing breast conservation versus single or double mastectomy
Catherine Pesce, Jennifer Jaffe, Kristine Kuchta, Katharine Yao, Mark Sisco
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations
Yi-Zhou Jiang, Li-Ping Ge, Xi Jin, Lei Fan, Min He, Yin Liu, Li Chen, Wen-Jia Zuo, Jiong Wu, Guang-Yu Liu, Gen-Hong Di, Zhong-Hua Wang, Ke-Da Yu, Zhi-Ming Shao
The value of mammography in women with focal breast complaints in addition to initial targeted ultrasound
L. Appelman, P. T. M. Appelman, C. C. N. Siebers, P. Bult, H. L. S. Go, M. Schlooz, R. M. Mann
Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers
Lee Galmor, Rinat Bernstein-Molho, Miri Sklair-Levy, Dana Madoursky-Feldman, Dov Zippel, Yael Laitman, Eitan Friedman
Prospective surveillance model in the home for breast cancer-related lymphoedema: a feasibility study
Louise A. Koelmeyer, Emma Moloney, John Boyages, Kerry A. Sherman, Catherine M. Dean
Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant
Karina Cox, Nicky Dineen, Sian Taylor-Phillips, Nisha Sharma, Catherine Harper-Wynne, Deborah Allen, Jennifer Weeks, Ritchie Chalmers, Deepika Akolekar, Russell Burcombe, Rema Jyothirmayi, Ali Sever
Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome
Matan Ben-Zion Berliner, Rinat Yerushalmi, Inbar Lavie, Alexandra Benouaich-Amiel, Daliah Tsoref, Daniel Hendler, Hadar Goldvaser, Michal Sarfaty, Ofer Rotem, Olga Ulitsky, Tali Siegal, Victoria Neiman, Shlomit Yust-Katz
A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients
Amit Goyal, Shama Puri, Andrea Marshall, Kalliope Valassiadou, Moin M. Hoosein, Amtul R. Carmichael, Gabriella Erdelyi, Nisha Sharma, Janet Dunn, Joanne York
Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study
Janine M. Simons, Julien G. Jacobs, Joost P. Roijers, Maarten A. Beek, Leandra J. M. Boonman-de Winter, Arjen M. Rijken, Paul D. Gobardhan, Jan H. Wijsman, Eric Tetteroo, Joan B. Heijns, C. Y. Yick, Ernest J. T. Luiten
Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention
Cynthia Villarreal-Garza, Fernanda Mesa-Chavez, Ma ria Alejandra Garza-Ledezma, Omar Peña-Curiel, Bertha Alejandra Martinez-Cannon, Mauricio Canavati-Marcos, Servando Cardona-Huerta
Effect of level of hormone-receptor expression on treatment outcomes of “triple-positive” early-stage breast cancer
Hikmat Abdel-Razeq, Sara Edaily, Sereen Iweir, Mourad Salam, Yacob Saleh, Maher Sughayer, Osama Salama, Rawan Mustafa, Yosra Al-Masri, Rayan Bater, Ayat Taqash
Genetic variants in anti-Müllerian hormone-related genes and breast cancer risk: results from the AMBER consortium
Hazel B. Nichols, Mariaelisa Graff, Jeannette T. Bensen, Kathryn L. Lunetta, Katie M. O’Brien, Melissa A. Troester, Lindsay A. Williams, Kristin Young, Chi-Chen Hong, Song Yao, Christopher A. Haiman, Edward A. Ruiz-Narváez, Christine B. Ambrosone, Julie R. Palmer, Andrew F. Olshan
Performance of a clinical and imaging-based multivariate model as decision support tool to help save unnecessary surgeries for high-risk breast lesions
Dogan S. Polat, Jennifer G. Schopp, Firouzeh Arjmandi, Jessica Porembka, Venetia Sarode, Deborah Farr, Yin Xi, Basak E. Dogan
Obesity and breast cancer risk for pre- and postmenopausal women among over 6 million Korean women
Jae Won Park, Kyungdo Han, Dong Wook Shin, Yohwan Yeo, Ji Won Chang, Jung Eun Yoo, Su-Min Jeong, Se-Kyung Lee, Jai Min Ryu, Yong-Moon Park
A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer
Christine Brezden-Masley, Kelly E. Fathers, Megan E. Coombes, Behin Pourmirza, Cloris Xue, Katarzyna J. Jerzak
Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study
L Findlay-Shirras, I Lima, G Smith, M Clemons, A Arnaout
Re: Stage-specific survival has improved for young breast cancer patients since 2000: but not equally?
Per-Henrik Zahl, Ivar Sønbø Kristiansen
Comments on patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer
Fernando Hernanz
Tumor localization for breast cancer patients receiving neoadjuvant chemotherapy
Zhen-Yu Wu, Namkug Kim, BeomSeok Ko